Creator of mRNA Vaccine Technology Tells Tucker Carlson: ‘Government Not Being Transparent’ About Vaccine Risks

All Global Research articles can be read in 51 languages by activating the “Translate Website” drop down menu on the top banner of our home page (Desktop version). 

Visit and follow us on Instagram at @crg_globalresearch.

***

Dr. Robert Malone told Tucker Carlson we know the vaccines pose risks, but it’s hard to assess them because the government isn’t capturing the data “rigorously enough,” so we don’t have the information we need to make a reasonable decision.

In the segment below on last night’s “Tucker Carlson Tonight,” Fox News commentator Tucker Carlson interviewed Dr. Robert Malone, creator of mRNA vaccine technology, about his opinion that COVID vaccines are unsafe for certain people, and how YouTube censored him for discussing vaccine safety.

YouTube took down an episode of the Dark Horse Podcast that featured an interview with Malone, despite Malone likely being “the single most qualified person on the planet” to discuss vaccine risks, Carlson explained. “He helped create the mRNA technology used in COVID vaccines.”

Malone told Carlson he’s concerned about vaccine safety in young people who are at low risk of becoming seriously ill or dying from COVID.

Malone’s comment followed news this week that within 24 hours of the World Health Organization (WHO) updating its guidance on who should get the COVID vaccine — with this statement: “Children should not be vaccinated for the moment” — the WHO removed the statement. The revised guidance now says the vaccines are “suitable for use” by children “over the age of 12.”

Malone told Carlson:

“One of my concerns is the government is not being transparent with us. I’m of the opinion that people have the right to decide whether to accept vaccines or not, especially since these are experimental vaccines. This is a fundamental right having to do with clinical research ethics.”

We know there are risks, but it’s hard to assess them because the government isn’t capturing the data “rigorously enough,” Malone said. “We don’t have the information we need to make a reasonable decision.”

Malone said the risk-benefit analysis has not been done.

“Normally, at this stage, Centers for Disease Control and Prevention’s Advisory Committee on Immunizations Practices would’ve performed those risk-benefit analyses,” said Malone. “They would be data-based and science-based. They’re not right now.”

Carlson also highlighted a Norwegian study linking the Pfizer vaccine to deaths in nursing home residents.

The study found that out of the first 100 reported deaths in nursing home residents who received the Pfizer vaccine, 10 were “likely” due to the vaccine. An additional 26 deaths were “possibly” caused by the vaccine, said the study authors.

Watch Tucker Carlson’s segment here:

*

Note to readers: Please click the share buttons above or below. Follow us on Instagram, @crg_globalresearch. Forward this article to your email lists. Crosspost on your blog site, internet forums. etc.

Featured image is a screenshot from the video


Disclaimer: The contents of this article are of sole responsibility of the author(s). The Centre for Research on Globalization will not be responsible for any inaccurate or incorrect statement in this article. The Centre of Research on Globalization grants permission to cross-post Global Research articles on community internet sites as long the source and copyright are acknowledged together with a hyperlink to the original Global Research article. For publication of Global Research articles in print or other forms including commercial internet sites, contact: [email protected]

www.globalresearch.ca contains copyrighted material the use of which has not always been specifically authorized by the copyright owner. We are making such material available to our readers under the provisions of "fair use" in an effort to advance a better understanding of political, economic and social issues. The material on this site is distributed without profit to those who have expressed a prior interest in receiving it for research and educational purposes. If you wish to use copyrighted material for purposes other than "fair use" you must request permission from the copyright owner.

For media inquiries: [email protected]